Sino-british precision medical cooperation press the accelerator button
On the afternoon of April 25, the Jiangbei District New Area and the UK’s P4 Precision Medicine Accelerator jointly held the 2022 Nanjing Jiangbei New Area sino-british precision medicine industry forum. This forum Invited guests from the Former Consulate-General of the United Kingdom, Shanghai, UCL and leading industry clusters to share the opportunities for international collaboration in the UK’s precision healthcare industry. It may help to foster innovative growth drivers and to open up a new direction of development. The Deputy Secretary for Nanjing Science and Technology, Wang Yuanhua, attended the forum and delivered a speech.
In his speech, Wang Yuanhua said that Nanjing attaches great importance to innovative co-operation with all sectors of the UK, especially the life and health industry. He wished that two sides will continue to make use of their technological advantages and continue to expand areas of co-operation, promote in-depth cooperation in the life and health industries, including precision medicine.
Ge Xiaoyong, Deputy Director of the central business district of Jiangbei new district, introduced the Great Health Industry of Jiangbei to the guests and leaders at the meeting. Then he extended welcome the UK’s leading international health innovation organization, well-known medical institutions and key enterprises to establish health industry cooperation in the new area, and strengthen innovation cooperation for mutual benefit.
Du Yan, NHSA investment manager at the Former Consulate-General of the UK, Shanghai, spoke on behalf of the UK government about opportunities in the north England healthcare technology industry. UCL P4 Precision Medical Accelerator co-founder Nathan McNally, UK Capital Enterprise CEO John Johan, and the relevant leaders of the NHSA respectively introduced about the Precision Medical Industry UK innovation ecology, innovation ecology to enable small and medium-sized medical technology enterprises and intellectual property rights identification and protection, and the North England Life Sciences Super Cluster.
A number of experts and scholars shared their experiences on the topic “opportunities and challenges of cross-border venture capital investment in precision medical technology and investment in the post-epidemic era”.
In recent years, the life and health industry in Jiangbei new district has developed vigorously. As an important platform for opening to the outside world, Jiangbei new district has a modern industrial system and an innovative ecological system that is deeply involved in international cooperation.
Among them, Jiangbei District new area and the United Kingdom have made closer interaction in the field of science and technology innovation, established channels of cooperation in Nanjing with UK well-known institutions, innovation platform, entrepreneurial projects and international capital.Including the Cambridge University — Nanjing Science and Innovation Center, which was established in collaboration with Cambridge University, is the first overseas innovation center established in the market cooperation mode; Established in partnership with King’s College London, the Nanjing University is labeled as the “Best in China, excellent in the world”, focus on immunology, oncology, geriatrics and advanced diagnosis and treatment technology in four cutting-edged directions for industrial-oriented research and innovations; The Nightingale Institute of Nursing has been established and put into use in the new international health city by collocating with King’s College London.
